# Kearny Financial Corp.: financial statements, quarterly

KRNY · Nasdaq · CIK 1617242 · [Financials](/sectors/financials.md) · fiscal year ends Jun 30

Pages: [Overview](/companies/krny.md) · [Financials](/companies/krny/financials.md) · [Filings](/companies/krny/filings.md) · [Insiders](/companies/krny/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/krny/financials.md?period=annual).

## Income statement

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [42.0](/filings/0001617242-23-000087.md) | [46.8](/filings/0001617242-24-000015.md) | [47.8](/filings/0001617242-24-000030.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [3.3](/filings/0001617242-24-000084.md) | [1.8](/filings/0001617242-25-000007.md) | [1.7](/filings/0001617242-25-000014.md) | [(0.9) d](/filings/0001617242-26-000020.md) | [1.1](/filings/0001617242-25-000073.md) | [1.3](/filings/0001617242-26-000004.md) | [1.2](/filings/0001617242-26-000009.md) | [1.4 d](/filings/0001617242-26-000020.md) | [2.5](/filings/0001617242-25-000073.md) | [2.3](/filings/0001617242-26-000004.md) | [2.5](/filings/0001617242-26-000009.md) | [3.8 d](/filings/0001617242-26-000020.md) |
| Net income | $m | [9.8](/filings/0001617242-24-000084.md) | [(13.8)](/filings/0001617242-25-000007.md) | [7.4](/filings/0001617242-25-000014.md) | [(90.1) d](/filings/0001617242-26-000020.md) | [6.1](/filings/0001617242-25-000073.md) | [6.6](/filings/0001617242-26-000004.md) | [6.6](/filings/0001617242-26-000009.md) | [6.8 d](/filings/0001617242-26-000020.md) | [9.5](/filings/0001617242-25-000073.md) | [9.4](/filings/0001617242-26-000004.md) | [10.1](/filings/0001617242-26-000009.md) | [7.2 d](/filings/0001617242-26-000020.md) |
| Diluted EPS | $ per share | [0.16](/filings/0001617242-24-000084.md) | [(0.22)](/filings/0001617242-25-000007.md) | [0.12](/filings/0001617242-25-000014.md) | not reported | [0.10](/filings/0001617242-25-000073.md) | [0.10](/filings/0001617242-26-000004.md) | [0.11](/filings/0001617242-26-000009.md) | not reported | [0.15](/filings/0001617242-25-000073.md) | [0.15](/filings/0001617242-26-000004.md) | [0.16](/filings/0001617242-26-000009.md) | not reported |
| Basic EPS | $ per share | [0.16](/filings/0001617242-24-000084.md) | [(0.22)](/filings/0001617242-25-000007.md) | [0.12](/filings/0001617242-25-000014.md) | not reported | [0.10](/filings/0001617242-25-000073.md) | [0.11](/filings/0001617242-26-000004.md) | [0.11](/filings/0001617242-26-000009.md) | not reported | [0.15](/filings/0001617242-25-000073.md) | [0.15](/filings/0001617242-26-000004.md) | [0.16](/filings/0001617242-26-000009.md) | not reported |

- Revenue: not reported
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [57.2](/filings/0001617242-23-000087.md) | [73.9](/filings/0001617242-24-000015.md) | [71.0](/filings/0001617242-24-000030.md) | [63.9](/filings/0001617242-25-000056.md) | [156](/filings/0001617242-24-000084.md) | [142](/filings/0001617242-25-000007.md) | [126](/filings/0001617242-25-000014.md) | [167](/filings/0001617242-26-000020.md) | [130](/filings/0001617242-25-000073.md) | [147](/filings/0001617242-26-000004.md) | [124](/filings/0001617242-26-000009.md) | [115](/filings/0001617242-26-000020.md) |
| Total assets | $m | [7,975](/filings/0001617242-23-000087.md) | [7,898](/filings/0001617242-24-000015.md) | [7,842](/filings/0001617242-24-000030.md) | [7,683](/filings/0001617242-25-000056.md) | [7,772](/filings/0001617242-24-000084.md) | [7,731](/filings/0001617242-25-000007.md) | [7,733](/filings/0001617242-25-000014.md) | [7,740](/filings/0001617242-26-000020.md) | [7,648](/filings/0001617242-25-000073.md) | [7,621](/filings/0001617242-26-000004.md) | [7,608](/filings/0001617242-26-000009.md) | [7,682](/filings/0001617242-26-000020.md) |
| Total liabilities | $m | [7,125](/filings/0001617242-23-000087.md) | [7,050](/filings/0001617242-24-000015.md) | [6,993](/filings/0001617242-24-000030.md) | [6,930](/filings/0001617242-25-000056.md) | [7,021](/filings/0001617242-24-000084.md) | [6,987](/filings/0001617242-25-000007.md) | [6,985](/filings/0001617242-25-000014.md) | [6,994](/filings/0001617242-26-000020.md) | [6,895](/filings/0001617242-25-000073.md) | [6,863](/filings/0001617242-26-000004.md) | [6,845](/filings/0001617242-26-000009.md) | [6,916](/filings/0001617242-26-000020.md) |
| Short-term borrowings | $m | [1,627](/filings/0001617242-23-000087.md) | [1,667](/filings/0001617242-24-000015.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [850](/filings/0001617242-25-000007.md) | [848](/filings/0001617242-25-000014.md) | [849](/filings/0001617242-25-000014.md) | [754](/filings/0001617242-26-000020.md) | [752](/filings/0001617242-26-000004.md) | [745](/filings/0001617242-26-000009.md) | [748](/filings/0001617242-26-000009.md) | [746](/filings/0001617242-26-000020.md) | [753](/filings/0001617242-26-000004.md) | [757](/filings/0001617242-26-000009.md) | [763](/filings/0001617242-26-000009.md) | [767](/filings/0001617242-26-000020.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [12.3](/filings/0001617242-24-000084.md) | [6.9 d](/filings/0001617242-25-000007.md) | [17.6 d](/filings/0001617242-25-000014.md) | [7.3 d](/filings/0001617242-26-000020.md) | [2.5](/filings/0001617242-25-000073.md) | [(2.7) d](/filings/0001617242-26-000004.md) | [16.8 d](/filings/0001617242-26-000009.md) | [8.1 d](/filings/0001617242-26-000020.md) | [1.5](/filings/0001617242-25-000073.md) | [14.3 d](/filings/0001617242-26-000004.md) | [7.9 d](/filings/0001617242-26-000009.md) | [14.0 d](/filings/0001617242-26-000020.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $m | [7.0](/filings/0001617242-24-000084.md) | [6.8 d](/filings/0001617242-25-000007.md) | [6.9 d](/filings/0001617242-25-000014.md) | [6.9 d](/filings/0001617242-26-000020.md) | [7.0](/filings/0001617242-25-000073.md) | [6.9 d](/filings/0001617242-26-000004.md) | [6.9 d](/filings/0001617242-26-000009.md) | [6.9 d](/filings/0001617242-26-000020.md) | [7.1](/filings/0001617242-25-000073.md) | [6.9 d](/filings/0001617242-26-000004.md) | [6.9 d](/filings/0001617242-26-000009.md) | [6.9 d](/filings/0001617242-26-000020.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: not reported

## Shares

| Line item | Unit | Q1 FY2023 (2022-09-30) | Q2 FY2023 (2022-12-31) | Q3 FY2023 (2023-03-31) | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [65.8](/filings/0001617242-23-000087.md) | [65.0](/filings/0001617242-24-000015.md) | [64.8](/filings/0001617242-24-000030.md) | [63.1](/filings/0001617242-24-000084.md) | [62.3](/filings/0001617242-25-000007.md) | [62.2](/filings/0001617242-25-000014.md) | [62.4](/filings/0001617242-25-000073.md) | [62.6](/filings/0001617242-26-000004.md) | [62.7](/filings/0001617242-26-000009.md) | [63.0](/filings/0001617242-25-000073.md) | [63.1](/filings/0001617242-26-000004.md) | [63.3](/filings/0001617242-26-000009.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 64,929,382 at 2026-08-19, from the cover of the [10-K filed 2026-08-21](/filings/0001617242-26-000020.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:44 ET. No prices; not investment advice.